Clinical Trials Logo

Filter by:
NCT ID: NCT05988606 Completed - Clinical trials for High-Intensity Interval Training

Work Rate Adjustments During a High-intensity Interval Training on a Stationary Bike in a Hot and Temperate Environment

Start date: May 12, 2021
Phase: N/A
Study type: Interventional

The goal of this repeated measures study is to evaluate acute work rate adjustments during high-intensity interval training (HIIT) in a hot and temperate environment in healthy and active adults when using target heart rate to prescribe the exercise intensity. The main questions it aims to answer are: - Will HIIT based on target heart rate in a hot environment result in increased cardiovascular (i.e., elevated recovery HR) and thermal strain compared to HIIT in a temperate environment? - Will work rate be lowered to a greater extent during HIIT in a hot environment compared to a temperate environment in order to maintain target heart rate? - Will maximal aerobic capacity (V̇O2max) decrease to a greater extent after HIIT in the heat compared to a temperate environment? Procedures: Participants will complete 5 trials on a cycle ergometer. Trial 1 (Control Visit): Participants (n = 7) will have their maximal heart rate and V̇O2max measured in a temperate environment (~22 °C, 40% RH). Experimental Trials 2-5: The order of the trials will be counterbalanced and randomly assigned to participants. - 15TEMP: Participants will cycle at 70% of their maximum heart rate for 8 minutes as a warm-up, followed by one round of HIIT. The HIIT protocol consists of 4 minutes at 90% of maximum heart rate followed by 3 minutes at 70% of maximum heart rate, totaling 15 minutes, in a temperate environment (~22 °C, 40% RH). After the HIIT session, a graded exercise test will measure V̇O2max. - 15HEAT: Similar to 15TEMP, but participants will perform the HIIT protocol in a hot environment (~35 °C, 40% RH). - 43TEMP: Participants will cycle at 70% of their maximum heart rate for 8 minutes as a warm-up, followed by the HIIT protocol repeated four times (4 minutes at 90% of maximum heart rate and 3 minutes at 70% of maximum heart rate), totaling 43 minutes, in a temperate environment (~22 °C, 40% RH). - 43HEAT: Similar to 43TEMP, but participants will perform the HIIT protocol in a hot environment (~35 °C, 40% RH).

NCT ID: NCT05988034 Completed - Electrocardiography Clinical Trials

A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

Start date: November 8, 2019
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the effects of therapeutic and supratherapeutic doses of avacopan on the heart rate corrected QT interval, using Fridericia's formula (QTcF).

NCT ID: NCT05988021 Completed - Clinical trials for Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168

Start date: December 3, 2015
Phase: Phase 1
Study type: Interventional

The primary objective of this clinical trial is to evaluate the effect of a high-fat, high-calorie meal on the pharmacokinetic (PK) profile of CCX168, following oral administration of a single dose of 30 mg CCX168 to healthy volunteers.

NCT ID: NCT05987917 Completed - Wrinkle Clinical Trials

Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-2 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and correcting facial skin laxity.

NCT ID: NCT05987709 Completed - Colon Cancer Clinical Trials

Study of Colorectal Cancer Screening Options

Start date: March 17, 2022
Phase: N/A
Study type: Interventional

The investigators propose to evaluate Guardant Health's commercially available colorectal cancer screening assay(Guardant SHIELD) in individuals who are not up to date with CRC screening.

NCT ID: NCT05987566 Completed - Hypertension Clinical Trials

Chronobiology of Meal Timing: Effects on Vascular and Renal Function

Start date: September 11, 2023
Phase: N/A
Study type: Interventional

The purpose of this study us to investigate the effects of mistimed eating on blood pressure, kidney function and vascular function.

NCT ID: NCT05986682 Completed - Multiple Myeloma Clinical Trials

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

Start date: September 18, 2023
Phase:
Study type: Observational

The purpose of this study is to describe the real-world use of Belantamab Mafodotin - blmf (BLENREP) and associated patterns of care, including dosing and dose modification, eye care specialist visits, associated healthcare utilization, and clinical outcomes in patients with relapsed and/or refractory multiple myeloma (RRMM) seen in the Duke Cancer Institute (DCI) clinics.

NCT ID: NCT05986591 Completed - COPD Clinical Trials

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

ARBORUS
Start date: August 17, 2022
Phase: Phase 3
Study type: Interventional

Bioequivalence Study of Tiotropium Bromide Inhalation Powder 18 μg

NCT ID: NCT05986565 Completed - Clinical trials for Fetal Alcohol Spectrum Disorders

Study of the Families Moving Forward Website Behavioral Intervention for Teachers of Students With Fetal Alcohol Spectrum Disorder

Start date: August 24, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if the FMF Connect Teacher Companion website is acceptable and usable by teachers. The FMF Connect Teacher Companion website is a website for teachers adapted from the Families Moving Forward (FMF) Program. The FMF Program is an evidence-based intervention for caregivers of children with FASD. The study will determine if the a web page intervention is feasible and acceptable by looking at enrollment and retention of study subjects and acceptability of assessments.

NCT ID: NCT05985928 Completed - Healthy Adults Clinical Trials

Sensory Study: Taste and Tongue Biology

SweetTaste
Start date: March 20, 2023
Phase:
Study type: Observational

Researchers will investigate the correlation between a) self-reported dietary intake of foods and beverages, b) intensity of sucrose stimuli, and c) liking rating of sweet stimuli, with the relative expression of the taste receptor genes from human fungiform papillae (TAS1R2 and TAS1R3). * This research will provide new information on how sweet taste perception is regulated. - The hypothesis: Greater dietary consumption of sugar and sweet foods is associated with reduced expression of the sweet taste receptors. - The results of this study could help to identify pathways to help modify sweet taste perception by uncovering this mechanism. Participants will sample solutions prepared with sweet ingredients, provide salivary DNA, and collect fungiform papillae. This will allow researchers and investigators to compare the relationship between the sweetness of stimuli, genetic differences in sweet taste receptors, and expression levels of sweet taste receptor genes.